Unicycive Therapeutics
UNCY
UNCY
30 hedge funds and large institutions have $27.4M invested in Unicycive Therapeutics in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
5.1% less ownership
Funds ownership: 40.69% → 35.59% (-5.1%)
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.85M | |
| 2 | +$512K | |
| 3 | +$292K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$231K |
| 5 |
Goldman Sachs
New York
|
+$197K |
Top Sellers
| 1 | -$104K | |
| 2 | -$56.2K | |
| 3 | -$55K | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$12.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HI
26
Harbour Investments
Madison,
Wisconsin
| $436 |
|
|||
27
Barclays
London,
United Kingdom
| $349 |
|
|||
28
BNP Paribas Financial Markets
Paris,
France
| $240 |
|
|||
|
BWL
29
Bogart Wealth LLC
Mclean,
Virginia
| $26 |
|
|||
|
DB
30
Danske Bank
Copenhagen K,
Denmark
| $4 |
|
|||
31
JP Morgan Chase
New York
| – |
|
|||
32
Renaissance Technologies
New York
| – |
|
|||
33
Lazard Asset Management
New York
| – |
|